Laboratory pipette with drop of liquid over glass test tubes in a science research lab

21 March 2023 - results

The international healthcare group has announced its final results for the year to 31 December, and these have seen modest growth of 1% in revenue to £172m.  However, underlying pre-tax profits have declined by 28% to £30.3m with earnings per share on the same basis down 33% to 4.28p.  Net debt rose 17% to £"102m although the dividend was raised by 5% to 1.776p per share.  Revenue growth during the year was less than expected due to the lockdown in China and supply chain disruption with destocking by customers also having a . . .

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.

Tagged: